These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32998419)

  • 1. Cytokine-Targeted Therapeutics for KSHV-Associated Disease.
    Alomari N; Totonchy J
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32998419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.
    Naimo E; Zischke J; Schulz TF
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking KSHV to human cancer.
    Wong EL; Damania B
    Curr Oncol Rep; 2005 Sep; 7(5):349-56. PubMed ID: 16091195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
    Katano H
    Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.
    He M; Cheng F; da Silva SR; Tan B; Sorel O; Gruffaz M; Li T; Gao SJ
    Cancer Treat Res; 2019; 177():23-62. PubMed ID: 30523620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T; Fujimuro M
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host-Level Susceptibility and IRF1 Expression Influence the Ability of IFN-γ to Inhibit KSHV Infection in B Lymphocytes.
    Alomari N; Totonchy J
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies.
    Patel R; Lurain K; Yarchoan R; Ramaswami R
    Expert Rev Anti Infect Ther; 2023; 21(9):929-941. PubMed ID: 37578202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus immune modulation: an overview.
    Rezaee SAR; Cunningham C; Davison AJ; Blackbourn DJ
    J Gen Virol; 2006 Jul; 87(Pt 7):1781-1804. PubMed ID: 16760382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
    Rivera-Soto R; Dissinger NJ; Damania B
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
    Kalt I; Masa SR; Sarid R
    Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis.
    Liang C; Lee JS; Jung JU
    Semin Cancer Biol; 2008 Dec; 18(6):423-36. PubMed ID: 18948197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).
    Polizzotto MN; Uldrick TS; Wyvill KM; Aleman K; Marshall V; Wang V; Whitby D; Pittaluga S; Jaffe ES; Millo C; Tosato G; Little RF; Steinberg SM; Sereti I; Yarchoan R
    Clin Infect Dis; 2016 Mar; 62(6):730-738. PubMed ID: 26658701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
    Carbone A; De Paoli P; Gloghini A; Vaccher E
    Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A variant of KSHV-associated inflammatory cytokine syndrome in elderly men of Mediterranean descent.
    Liapis K; Bouzani M; Petrakis V; Anagnostopoulos NI; Kotsianidis I
    Infection; 2024 Jun; 52(3):1175-1180. PubMed ID: 38113021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
    Li S; Bai L; Dong J; Sun R; Lan K
    Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
    Ramaswami R; Lurain K; Marshall VA; Rupert A; Labo N; Cornejo-Castro E; Miley W; Wang HW; Widell A; Lindsley M; Yuan C; Stetler-Stevenson M; Filie AC; Whitby D; Ziegelbauer JM; Uldrick TS; Yarchoan R
    AIDS; 2021 Jan; 35(1):53-62. PubMed ID: 33273183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KSHV-Mediated Angiogenesis in Tumor Progression.
    Purushothaman P; Uppal T; Sarkar R; Verma SC
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27447661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KSHV: Immune Modulation and Immunotherapy.
    Broussard G; Damania B
    Front Immunol; 2019; 10():3084. PubMed ID: 32117196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.